-
Study Highlights Challenges in Pancreatic Cancer Staging
Most pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles
-
November 22: The Week in Cancer News
Pancreatic cancer surge in younger people has not led to a rise in deaths, and researchers will study long-term survivors to better understand cancer responses.
by Eric Fitzsimmons
-
Understanding How High and Low Testosterone Levels Can Treat Prostate Cancer
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
-
November 15: The Week in Cancer News
Complications can affect men years after prostate cancer treatment, and many people eligible for lung cancer screening do not get it.
by Kevin McLaughlin
-
Financial Screenings for People with Cancer
Cancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
-
November 8: The Week in Cancer News
Early initiation of palliative care leads to fewer hospital admissions, and surgery that removes fewer lymph nodes is effective for localized muscle-invasive bladder cancer.
by Marci A. Landsmann
-
November 1: The Week in Cancer News
Long-term monitoring can catch side effects in childhood cancer survivors, and breast cancer screening rates remain low among transgender people.
by Thomas Celona
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles